Education
About Us
Working with TipRanks
Follow Us
Rekah Pharmaceutical Industry Ltd. (IL:REKA)
:REKA
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | 321.71M | 321.66M | 292.39M | 263.95M | 265.47M |
| Gross Profit | 71.95M | 80.20M | 78.70M | 65.16M | 68.64M |
| Operating Income | 16.37M | 2.91M | 13.25M | 14.14M | 20.92M |
| EBITDA | 47.30M | 26.03M | 40.24M | 36.20M | 39.68M |
| Net Income | 6.21M | -6.91M | -2.04M | 6.62M | 10.80M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | 7.07M | 19.35M | 20.29M | 18.64M | 36.93M |
| Total Assets | 447.22M | 484.72M | 448.42M | 437.09M | 419.69M |
| Total Debt | 134.16M | 178.90M | 154.38M | 165.82M | 166.34M |
| Net Debt | 127.13M | 159.59M | 134.17M | 147.22M | 129.45M |
| Total Liabilities | 285.24M | 329.14M | 286.34M | 264.02M | 254.10M |
| Stockholders' Equity | 161.93M | 155.54M | 162.03M | 173.01M | 165.53M |
| Cash Flow | |||||
| Free Cash Flow | 17.84M | 16.86M | 31.52M | 7.17M | -7.55M |
| Operating Cash Flow | 26.54M | 28.35M | 39.00M | 21.17M | 11.28M |
| Investing Cash Flow | 15.29M | -21.50M | -13.45M | -35.90M | -18.74M |
| Financing Cash Flow | -54.13M | -7.78M | -24.36M | -2.78M | 19.08M |
Rekah Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.